Literature DB >> 8489500

Intracellular maturation of the gamma-carboxyglutamic acid (Gla) region in prothrombin coincides with release of the propeptide.

R Wallin1, C Stanton, S M Hutson.   

Abstract

Vitamin K-dependent coagulation factors undergo several post-translational modifications before the proteins are secreted into the blood as functional zymogens of the coagulation system. The modifications include Asn-linked glycosylation, Asn/Asp hydroxylation, removal of a signal peptide for translocation of the polypeptide into the endoplasmic reticulum and removal of a propeptide which, when attached to the intracellular coagulation factor precursor, directs the protein for vitamin K-dependent gamma-carboxylation. gamma-Carboxylation of targeted Glu residues results in formation of Ca(2+)-binding gamma-carboxyglutamic acid (Gla) residues. Ca2+ binding by these residues induces a conformational change in the protein which is a necessary event for optimal activation or activity of the clotting factor in blood. In the present study we have monitored the intracellular prothrombin precursor in the secretory pathway of liver cells to determine the effect that the propeptide has on Ca(2+)-dependent folding of the protein. The data provide evidence that the Ca(2+)-induced conformational change required for activation of prothrombin coincides with release of the propeptide in the trans-Golgi apparatus of the liver cell and elucidates an important function for the endoproteinase furin in biosynthesis of vitamin K-dependent clotting factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489500      PMCID: PMC1132428          DOI: 10.1042/bj2910723

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Propeptide recognition by the vitamin K-dependent carboxylase in early processing of prothrombin and factor X.

Authors:  R Wallin; R Turner
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid.

Authors:  G L Nelsestuen
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

Review 3.  Molecular basis of vitamin K-dependent gamma-carboxylation.

Authors:  B Furie; B C Furie
Journal:  Blood       Date:  1990-05-01       Impact factor: 22.113

4.  Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. Conformation-specific antibodies directed against the phospholipid-binding site on prothrombin.

Authors:  M Borowski; B C Furie; S Bauminger; B Furie
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

5.  Amino-terminal alanine functions in a calcium-specific process essential for membrane binding by prothrombin fragment 1.

Authors:  D J Welsch; G L Nelsestuen
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

Review 6.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

7.  A structural model of human erythrocyte band 2.1: alignment of chemical and functional domains.

Authors:  R Wallin; E N Culp; D B Coleman; S R Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties.

Authors:  J Ware; D L Diuguid; H A Liebman; M J Rabiet; C K Kasper; B C Furie; B Furie; D W Stafford
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

9.  Vitamin K and the biosynthesis of prothrombin. V. Gamma-carboxyglutamic acids, the vitamin K-dependent structures in prothrombin.

Authors:  P Fernlund; J Stenflo; P Roepstorff; J Thomsen
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

10.  Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor.

Authors:  D L Diuguid; M J Rabiet; B C Furie; H A Liebman; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

View more
  3 in total

1.  A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine.

Authors:  Matthew G McDonald; Catherine K Yeung; Aaron M Teitelbaum; Amanda L Johnson; Shinya Fujii; Hiroyuki Kagechika; Allan E Rettie
Journal:  J Lipid Res       Date:  2019-01-22       Impact factor: 5.922

2.  Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.

Authors:  E G Wojcik; M Van Den Berg; S R Poort; R M Bertina
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity.

Authors:  Suziy de M Bandeira; Glaucevane da S Guedes; Lucas José S da Fonseca; André S Pires; Daniel P Gelain; José Claudio F Moreira; Luíza A Rabelo; Sandra Mary L Vasconcelos; Marília Oliveira F Goulart
Journal:  Oxid Med Cell Longev       Date:  2012-11-08       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.